Viewing Study NCT07189793


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2025-12-25 @ 11:13 PM
Study NCT ID: NCT07189793
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-24
First Post: 2025-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module